RXRX — Recursion Pharmaceuticals Inc

Healthcare · Biotechnology · Applied AI: industrial, defense & vertical

About Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States and the United Kingdom. The company develops REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-617, which is in Phase 1/2 clinical trial to treat advanced solid tumors; REC-1245, which is in Phase 1/2 clinical trial to treat biomarker-enriched solid tumors and lymphoma; REC-3565 that is in Phase 1/2 for the treatment of relapsed or refractory B-cell malignancies; and REC-4539, a reversible, CNS penetrant, orally bioavailable, and potential best-in-class inhibitor of LSD1 for the treatment of solid tumors and hematology

Applied AI: industrial, defense & vertical

These companies apply AI and autonomy to specific real-world domains — industrials, defense, space, robotics and other verticals. The link to AI runs through software, sensors, autonomy and the data these systems generate and analyze. Many are earlier-stage or project-driven, so results can be lumpy and tied to government budgets, contract timing and execution. Recursion Pharmaceuticals Inc is tracked in this sub-theme as a Biotechnology name — see the full Applied AI: industrial, defense & vertical list.

Key data · delayed ~15 min, as of 8 July 2026

TickerRXRX
CompanyRecursion Pharmaceuticals Inc
Price$3.96
Market cap$2.7B
Sector / industryHealthcare / Biotechnology
Performance1W +12.5% · 1M +14.1% · 1Y -19.7%
Analyst mean target$7 (7 analysts, none)

Valuation read

What the price implies: no positive forward earnings to anchor a growth read — this name is priced on revenue and story, not profits. Watch the path to profitability rather than a multiple.

Chart

Related in Applied AI: industrial, defense & vertical

SPCXTSLAIBMISRGHONROKCGNXAVAVSYMUPSTSMRINODBBAI

See the full picture on the AI stocks bubble map, gauge froth with the AI bubble-risk index, or stress-test your exposure.

Run a fair-value read on RXRX — free.

Create a free Santro AI account to run unlimited valuations, save RXRX to a watchlist, and set price alerts.

Create a free account →

Market data is delayed ~15 minutes and provided for education, not as financial advice. "Hot" means attention, not direction.